[Partial splenectomy in homozygous beta-thalassemia]

Area of Science:

• Pediatric Surgery
• Hematology
• Immunology

Background:

• Homozygous beta-thalassemia often leads to splenomegaly and high blood transfusion needs.
• Surgical intervention is considered for managing these complications in affected children.

Purpose of the Study:

• To evaluate the efficacy of partial splenectomy in managing homozygous beta-thalassemia.
• To assess the impact of partial splenectomy on blood transfusion requirements and spleen size.

Main Methods:

• Six children aged 2.5 to 6 years with homozygous beta-thalassemia underwent partial splenectomy.
• Blood transfusion volumes and spleen size were monitored post-surgery.

Main Results:

• Two children showed a marked reduction in blood transfusion needs (up to 150 ml/kg/year).
• Four children required total splenectomy due to persistent high transfusion requirements and rapid spleen regrowth.
• Spleen residue immunological function remains unclear.

Conclusions:

• Partial splenectomy may benefit selected children with homozygous beta-thalassemia.
• Careful patient selection is crucial for partial splenectomy success.
• Further research is needed on the spleen residue's immunological role.